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Abstract: The advent of innovative surgical procedures utilizing
partial thickness corneal grafts has created a need for the devel-
opment of synthetic implants to recreate corneal stromal tissue.
This work evaluates electrospun gelatin and polycaprolactone
(PCL) scaffolds as a potential biomaterial suitable for use
in regeneration of corneal stromal tissue. Electrospun gelatin
has been used for many years in tissue engineering; however,
post-production modiﬁcation, such as crosslinking, is usually
required to mechanically strengthen such scaffolds. This article
aims therefore to compare glutaraldehyde (GA) crosslinked
electrospun gelatin scaffolds with electrospun blends of gelatin
and PCL at different ratios. Scaffolds were fabricated using elec-
trospinning and characterized by scanning electron micros-
copy, Attenuated Total Reﬂectance-Fourier Transform Infrared
Spectroscopy, and tensile testing. To evaluate biocompatibility,
primary human corneal stromal cells (hCSC) were seeded upon
the scaffolds to assess adherence, proliferation, and phenotype.
Results demonstrated that scaffolds fabricated from mixtures
of gelatin and PCL showed increased mechanical strength and
plasticity compared to scaffolds fabricated from GA crosslinked
gelatin alone. In addition, scaffolds fabricated from PCL and
gelatin showed comparable support of hCSC adhesion and pro-
liferation. In conclusion, blended mixtures of gelatin and PCL
can be considered as an option in the selection of corneal
repair materials in the future. © 2018 The Authors. Journal of Bio-
medical Materials Research Part A published by Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 107A: 828–838, 2019.
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INTRODUCTION
Developments in corneal surgery over the last 15 years
have seen a paradigm shift in the way corneal donor tis-
sue is used.1 Skilled surgeons now have the option to
treat corneal blindness using partial thickness corneal
transplantation, a highly effective and safe alternative to
full-thickness transplantation.2 For example, Deep Ante-
rior Lamellar Keratoplasty (DALK), is a procedure in
which only the anterior portion of the cornea is removed
and replaced with a prepared portion of donor corneal
tissue. DALK has been shown to deliver clinical beneﬁts
relative to full thickness transplantation including fewer
post-operative complications while delivering similar
refractive outcomes and graft survival rates.3 The rise of
DALK is now driving the development of stromal mimetic
alternatives suitable for grafting.4
The corneal stroma makes up ~90% of the cornea and is
composed of orthogonally stacked lamellae of collagen I
ﬁbrils separated by proteoglycans and interspersed with a
quiescent cell population known as keratocytes.5,6 A chal-
lenge in developing a successful partial thickness tissue-
engineered cornea is mimicking this structure which has
been accomplished with some success using electrospinning.
Control over electrospinning parameters can yield scaffolds
with features in the micro to nano scale similar to the native
extracellular matrix.7 Electrospun scaffolds of natural bio-
polymers for tissue engineering applications have been suc-
cessfully reported by numerous groups.8,9 However, reports
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of protein denaturation post-electrospinning and high cost of
goods have limited the translation of such constructs.10 Gela-
tin is a natural biopolymer derived from the controlled
hydrolysis of collagen and has seen clinical use in a number
of medical areas. It has several advantages over collagen, as
it can be electrospun without further denaturation, there is
less potential for prion transmission and immunogenic and
antigenic reactions, and is less expensive.10,11
While gelatin appears an ideal material for stromal recon-
struction, its solubility in aqueous systems requires a level of
post-production modiﬁcation. Glutaraldehyde (GA) has been
frequently used to crosslink structural biopolymers; however,
reports of accelerated calciﬁcation of such constructs in vivo12
have seen many groups seek alternative strategies for
mechanically strengthening electrospun gelatin. These have
included chemical crosslinking,13 coaxial spinning,14 and
blending with less-brittle synthetic polymers.15–17 Poly-
ε-caprolactone (PCL), with its history of use in the body, has
been previously used to this end.18
The use of GA crosslinked (CL) electrospun gelatin and
gelatin/PCL electrospun blends have not previously been
reported in corneal tissue engineering. This work evaluates
these biomaterial systems in terms of physiochemical and
mechanical properties, and ultimately their inﬂuence on the
phenotype of primary human corneal stromal cells (hCSC),
derived from corneal keratocytes. We anticipate that the use of
such stromal constructs to be suitable for clinical situations
where the endothelium remains intact yet there is a need to
support stromal replacement.
MATERIALS AND METHODS
Materials
Unless otherwise speciﬁed, materials were purchased from
Sigma-Aldrich, United Kingdom.
Electrospinning
Gelatin type A (300 bloom, from porcine skin) and PCL (Mw
80,000) were dissolved in 1,1,1,3,3,3 Hexaﬂuoroisopropanol
(HFIP) by stirring at 37C overnight, to obtain polymer solutions
of 8% (w/v). Fibrous mats were produced by electrospinning
solutions of: 100% gelatin (100:0); 50% gelatin, 50% PCL
(50:50); 25% gelatin, 75% PCL (25:75); and 100% PCL (0:100)
in HFIP as summarized in Table I. Electrospinning was per-
formed though a syringe ﬁtted with a blunt 18G stainless steel
needle (0.84 mm internal diameter) attached to a syringe pump
(Harvard Apparatus) set to ﬂow rates between 0.75 and
2 mL/h, at a voltage of 15–20 kV. Fibers were collected on a
grounded stainless steel plate (10 × 15 cm) over a working dis-
tance of 15–20 cm. After spinning a total volume of 3.5 mL/plate,
ﬁbrous mats were detached from the collector plates and placed
in a vacuum oven (Heraeus Thermo Vacuum, VT6025) for 24 h
to remove residual HFIP. Glass coverslips (2D controls;
400 mm2) were immersed in 8% (w/v) solutions of gelatin and
PCL (same ratios as above) for 1 min and solvent removed as
described above.
Crosslinking gelatin and gelatin:PCL scaffolds
Electrospun gelatin and gelatin: PCL mats (100:0, 50:50,
25:75, and 0:100) were afﬁxed into CellCrown™ scaffold
holders (Scaffdex©, Finland) and placed in a sealed tank
(8 × 8 × 5 cm), suspended 3 cm above a 1% (v/v) GA solu-
tion for 24 h at room temperature (RT). After crosslinking,
samples were immersed in 200 mM glycine at RT for 1 h to
block any free residual GA groups.
Scanning electron microscopy including environmental
SEM (ESEM)
Electrospun mats were sputter-coated with gold for 5 min at
25 mA (Leica EM SCD005, Germany) and ﬁber morphologies
were assessed using a scanning electron microscope (SEM;
JEOL SM 1100, United Kingdom). Images were acquired of
three independent batches of electrospun material each in trip-
licate and analyzed using Image J© v1.47i to determine the
mean ﬁber thickness (mean of 20 measurements for each repli-
cate; 60 measurements in total per batch). Cross-sections of the
mats were imaged by SEM to determine thickness (three indi-
vidual batches; 6–10 measurements per batch). Morphology of
ﬁbrous mats (100:0 CL and 100:0) in the hydrated state was
assessed using ESEM imaging (Philips XL30 ﬁeld emission gun
ESEM; 3.6 Torr).
Porosity measurements
The porosity of each scaffold was estimated using a pub-
lished method.19 In brief, scaffolds were weighed and size
measured using a micrometer (Sylvac, Fowler, United King-
dom) to calculate the apparent density [Eq. (1)].
apparent density
g
cm3
 
¼ matmass gð Þ
mat thickness cmð Þ×mat area cm2ð Þ
ð1Þ
Using bulk densities obtained from the literature, [gelatin
1.3 g/cm3 (Ref. 20 and PCL 1.14 g/cm3 (Ref. 21)], the ratio of
the apparent and bulk densities of the materials (n = 3 indi-
vidual batches) was used to estimate the porosity [Eq. (2)].
mat porosity %ð Þ¼ 1 – mat apparent density g=cm
3ð Þ
material bulk density g=cm3ð Þ × 100% ð2Þ
TABLE I. Electrospinning Conditions for Fabrication of Gelatin:PCL Electrospun Scaffolds
Polymer Blend
(Gelatin:PCL)
Polymer Conc.
(w/w) (%)
Working
Distance (mm)
Working
Voltage (kV)
Flow Rate
(ml/h)
Spinning
Volume (ml)
Spinning
Time (min)
100:0 8.0 150 12.5 0.75 3.5 280
50:50 8.0 150 15 2.0 3.5 105
25:75 8.0 150 15 0.8 3.5 265
0:100 8.0 200 20 0.8 3.5 265
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Attenuated total reﬂectance-Fourier transform infrared
spectroscopy (ATR-FTIR)
Chemical analysis of the scaffolds was performed by ATR-
FTIR spectroscopy (Varian 660-IR FTIR using ATR sampler
accessory) over a range of 400–4000 cm−1. Assessment of
gelatin and PCL content was made through comparison of
the ratio of integrated peak areas (PCL ester peak at
1724 cm−1; gelatin amide I peak at 1652 cm−1). Pseudo-
Voigt peak ﬁtting was performed using Fityk v0.9.8 software
and using corrected baselines.22
Water contact angle
Water contact angle (WCA) was determined using a CAM200
instrument (KSV Instruments Ltd.). Droplets of ultra-pure
water (2–10 μL; 18.2 MΩ resistivity at RT) were dispensed
upon scaffolds secured to a microscope slide. The Young–
Laplace function was used to model and ﬁt the droplet, using
two radii of curvature. Mean and standard deviation were
calculated from measurements of ﬁve different samples for
each scaffold or coated glass coverslip.
Mechanical strength
Moduli and elongation at break were measured at a rate of
extension of 5 mm/min using an electromechanical universal
tester (Instron 50 kN 3342, Canton, MA equipped with
Series IX/S software). Rectangular sections of scaffold
(300 × 4 mm) were mounted within a sealed acetate frame
(minimum n = 3 for each treatment). Effects wof hydration
and GA crosslinking were tested by immersion of scaffolds
in PBS for 2 h at RT prior to testing. From the stress–strain
curves generated, the tensile strength and Young’s modulus
were determined. The tensile strength was taken as the max-
imum stress and the Young’s modulus was calculated from
the linear portion of the stress–strain curve.
Human corneal stromal cell isolation, expansion and
culture on scaffolds
Donor human corneas deemed unsuitable for transplantation
were acquired from the Manchester Eye Bank following consent
obtained from the donors or their relatives and anonymization.
Research was approved by the local ethics research committee
(07/H0403/140) and in accordance with the tenets of the Decla-
ration of Helsinki. Three independent patient donors (n = 3; in
order to take into account patient to patient variability) were
used for this study. Cells were extracted from corneoscleral rims
by collagenase digestion as previously described.23 Cells were
cultured in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM), sup-
plemented with 10% (v/v) fetal calf serum, 0.2 mM L-glutamine,
and 1% (v/v) antibiotic-antimycotic (ABAM, 10,000 units/mL
penicillin, 10 mg/mL streptomycin; 25 mg/mL amphotericin B;
Fibroblast [F] medium). For seeding onto scaffolds, the electro-
spun mats were mounted into CellCrown scaffold holders
(80 mm2) and sterilized using a 254 nm UVP XX-15W UV lamp
for 20 min and soaked in 1% (v/v) ABAM solution for 8 h, fol-
lowed by pre-soaking in F medium for 24 h. hCSC (passage 2)
were seeded onto scaffolds at a density 2 × 104 cells/cm2 in F
medium. To drive hCSCs toward a keratocyte phenotype, hCSC
were cultured in DMEM/F12 (Lonza, Belgium) supplemented
with 1% (v/v) ABAM, 1 μg/mL human insulin and 1 mM L-
Ascorbic acid-2-phosphate; Keratocyte (K) medium). Culture,
expansion, and differentiation of hCSCs followed methods previ-
ously described.23,24 Cells were expanded and used in all experi-
ments at passages 2 and 3.
Analysis of cell-scaffold interactions
PrestoBlue® assays (Life Technologies, United Kingdom)
were performed on days 1, 3, 6, and 12 according to the
manufacturer’s protocol to assess cell viability. In brief, scaf-
folds were washed with Hanks Buffered Saline Solution
(HBSS) and incubated with 10% (v/v) PrestoBlue stock
diluted in HBSS for 30 min at 37C. Fluorescence at excita-
tion 560 nm/emission 590 nm was measured using a ﬂuoro-
metric plate reader (Tecan Inﬁnite 1000, United Kingdom).
Transparency of constructs seeded with 1 × 105 cells/cm2
hCSC was evaluated by placing over laminated sheets of text
(letter A) after 12 days in culture and compared to acellular
controls (images captured using an EOS 100D digital camera;
Canon, Chichibu, Japan).
Reverse-transcription-quantitative polymerase chain
reaction
For gene expression, hCSC were seeded on scaffolds at a
density of 1 × 105 cells/cm2 and cultured for 12 days in K
medium. RNA extraction, cDNA synthesis, and qPCR were
performed as previously described.23 Quantitative PCR reac-
tions were performed with a 2 μL cDNA volume using inventor-
ied Taqman Assays (Applied Biosystems, Life Technologies):
GAPDH (Hs99999905_m1), CD34 (Hs00990732_m1), ALDH3A1
(Hs00964880), ACTA2 (Hs00426835_g1), and THY1 (Hs00
17816_m1). Ampliﬁcation was performed using an AB7500
quantitative PCR machine (Applied Biosystems) and analyzed
using AB7500 SDS v.2.0 software. Relative expression levels
were determined using the 2−ΔΔ(CT) method and normalized to
readings of GAPDH. RNA was isolated from hCSC cultured on
triplicate samples of each scaffold and pooled; three separate
experiments were performed to generate n = 3 data.
Sectioning and immunostaining of constructs
Cell-seeded scaffolds were ﬁxed in 4% (w/v) paraformaldehyde
at RT for 20 min. Samples were dehydrated though a series of
TABLE II. Antibodies used for Immunocytochemistry
Antibody Supplier Dilution
Primary Antibodies
Polyclonal rabbit
anti-ALDH3A1
Abcam 1:100
Monoclonal mouse
anti-α-SMA clone 1A4
Abcam 1:200
Polyclonal rabbit anti-CD34 Santa Cruz 1:50
Monoclonal mouse
anti-CD90 clone AF-9
Abcam 1:200
Secondary Antibodies
Donkey anti-mouse
Alexa-Fluor 594
Life Technologies 1:300
Donkey anti-rabbit
Alexa Fluor 488
Life Technologies 1:300
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graded alcohol solutions in a tissue processor (Leica TP1020)
and parafﬁn-embedded. Sections of 8 μm were cut (Leica RM
2165 microtome) and placed onto microscope slides. Samples
were deparafﬁnized in xylene, rehydrated in a series of graded
alcohol solutions, and antigen retrieval achieved in a pH 6.0
sodium citrate buffer at 95C for 60 min. Immunoﬂuorescent
staining was performed as described previously23 using the
antibodies detailed in Table II. Samples were counterstained
with 40,6-diamidino-2-phenylindole (1:200,000), mounted in
ﬂuorescent mounting medium (Dako, United Kingdom) and
imaged under an Olympus BX51 upright microscope using the
associated Olympus Cell^ F software.
FIGURE 1. Representative SEM images of gelatin:PCL electrospun scaffolds showing (A) 100:0; (B) 50:50; (C) 25:75, and (D) 0:100. ATR-FTIR spectra
of the four electrospun scaffolds showing transmittance in the region of interest between 800 and 1900 cm−1 (D). FTIR spectra of 0:100, 25:75, and
50:50 present PCL-related stretching modes present at 1724 cm−1 (carbonyl stretching), 1293 −1 (C O and C C stretching), and 1240 cm−1 (asym-
metric C O C stretching). Spectra of 100:0, 50:50, and 25:75 present protein related bands at 1652 cm−1 (amide I) and 1542 cm−1 (amide II). A com-
parison of the peak area ratio of PCL speciﬁc peak at 1724 cm−1 and gelatin speciﬁc peak at 1652 cm−1 in the ATR-FTIR spectra of electrospun
scaffolds of varying compositions (F).
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Statistical analysis
Results are expressed as mean  SEM unless otherwise
described. Statistical signiﬁcance for material characteriza-
tion studies was estimated by one-way ANOVA tests in
GraphPad Prism v6.01 followed by Tukey post hoc test to
compare groups. Cell data were analyzed by two-way
ANOVA followed by a Bonferroni post hoc test. Levels of sig-
niﬁcance were expressed as p values versus the control
(*p < 0.05, **p < 0.01, ***p < 0.001).
RESULTS
Fibrous scaffolds composed of gelatin and PCL were
fabricated
SEM images showed gelatin scaffolds (100:0) were composed
of ribbon-like ﬁbers [Fig. 1(A)], distinct from the rounded ﬁbers
observed for PCL (0:100) scaffolds [Fig. 1(D)]. Both 50:50 and
25:75 scaffolds showed signs of ribboning within the matrix
[Fig. 1(B,C)]. Characterization of scaffolds in terms of ﬁber and
scaffold thickness, porosity and WCA are presented in Table III.
TABLE III. Characterization of Scaffolds, Describing ﬁber Diameter, Scaffold Thickness, Porosity, and Water Contact Angle
(WCA).
Polymer Blend (Gelatin:PCL) Fiber Thickness (μm) Scaffold Thickness (μm) Porosity (%) WCA ()
100:0 2.20  1.02 75.03  16.06 65.57  12.74 40.30  5.46
50:50 0.89  0.58 73.62  10.05 73.28  19.23 55.51  19.38
25:75 0.63  0.22 76.00  12.21 63.94  16.89 44.47  8.92
0:100 0.62  0.47 62.15  22.44 88.75  3.31 85.37  6.87
All measurements are represented by mean  SD (n = 3).
FIGURE 2. Characterization of GA crosslinked (CL) 100:0 (Gelatin:PCL) electrospun scaffolds. (A) Representative SEM images of 100:0 (Gelatin:PCL)
electrospun scaffold (prior to crosslinking); (B) Representative SEM image of GA CL 100:0 (Gelatin:PCL) scaffold; (C) FTIR trace of 100:0 and 100:0
CL (Gelatin:PCL) scaffolds showing characteristic aldimine peak at 1450 cm−1. (D) Comparison of physical properties of GA CL 100:0 and 100:0
(Gelatin:PCL) scaffolds. All measurements represented as mean  SD (n = 3). Representative environmental scanning electron microscopy ESEM
images of electrospun scaffolds (E) GA CL 100:0 (Gelatin:PCL) scaffold and (F) 0:100 (Gelatin:PCL) scaffold. Scale bar 20 μm.
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Fiber thickness was notably larger in the 100:0 scaffolds
(2.20  1.02 μm), relative to the other scaffolds containing PCL
(0.89 0.58 to 0.62 0.47 μm). Scaffold thicknesses for all for-
mulations were relatively consistent (62–76 μm).
WCA of the electrospun scaffolds showed a marked dif-
ference between scaffolds made from the pure materials
(100:0–40.3  5.46 and 0:100–85.4  6.9). However, no
relationship between material composition and WCA was
observed in scaffolds generated from blends of the two
materials (50:50 55.5  19.4 and 25:75–44.5  8.9). In
assessing the porosity of the scaffolds, no relationship was
observed between material composition and porosity
(100:0–65.6%; 50:50 73.3%; 25:75–63.4%; 0:100–88.75%
porosity).
ATR-FTIR was used to conﬁrm the chemical composition
of the scaffolds. Figure 1(E) displays the key region of inter-
est presenting the percentage transmittance for each scaffold
offset by 10%. Gelatin related amide bands at 1652 cm−1
(amide I) and 1542 cm−1 (amide II) were observed in all gel-
atin containing scaffolds (100:0, 50:50, and 25:75). PCL-
related ester bands were conﬁrmed in 0:100, 25:75, and
50:50 scaffolds at 1724 cm−1 (carbonyl stretching),
1293 cm−1 (C O and C C stretching), and 1240 cm−1
(asymmetric C O C stretching). To assess the ratio of ester
to amide, FTIR peaks at 1724 and 1652 cm−1 were inte-
grated [Fig. 1(F)]. The 50:50 and 25:75 scaffolds were
observed to have distinctly different ratios of the two bands
(50:50–0.46; 25:75–0.32). To enhance the mechanical prop-
erties (and prevent dissolution of the gelatin in later cell cul-
ture studies) of 100:0 gelatin:PCL scaffolds, samples were CL
over GA vapor for 16 h. SEM images of the 100:0 scaffold
before [Fig. 2(A)] and after crosslinking [Fig. 2(B)], show a
distinct change in the ﬁbrous morphology of the scaffold
and as a consequence, ﬁber diameters in the CL scaffold
were not measurable. ATR-FTIR analysis of the scaffolds
before and after GA crosslinking shows an increase in
transmittance percentage at 1450 cm−1 corresponding to
an aldimine group [Fig. 2(C)]. After crosslinking, the scaf-
folds became notably less porous (100:0–65.6%; 100:0
CL–33.7%); however, there was little difference observed
between scaffold thickness (100:0–75.03 μm  16.1; 100:0
CL–70.82 μm  10.05) [Fig. 2(D)]. ESEM images were
acquired of both CL gelatin (100:0 CL) and PCL (0:100)
scaffolds in a partially hydrated state [Fig. 2(E,F)] conﬁrm-
ing a ﬁbrous structure.
Hydration inﬂuences the mechanical properties of the
scaffolds
Tensile testing of scaffolds with four different ratios of gela-
tin:PCL, before and after crosslinking for all samples and
following hydration is shown in Figure 3. In the dry state,
the tensile modulus (E) decreased with increasing PCL con-
tent ranging from 136 MPa  61 (100:0) down to
15 MPa  5 (0:100) [Fig. 3(A)]. In the hydrated state, this
FIGURE 3. Mechanical testing of electrospun scaffolds. Young’s Modulus (A,B) and elongation at break (C & D) of scaffolds before (control) and after
glutaraldehyde (GA) crosslinking (CL), both in dry (A,C) and hydrated states (B,D). Data presented as mean  SEM, n = 4. ( — denotes literature
values for the lower limit of full thickness corneal tissue.25 *p < 0.05, **p < 0.01, ***p < 0.001.
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trend reversed and the modulus increased with increasing
PCL content [Fig. 3(B)]. The 0:100 and 25:75 scaffolds
recorded similar moduli in both wet and dry states (Dry
25:75–40.6 MPa  15.2; 0:100–15.5 MPa  2.3; Wet
25:75–39 MPa  8; 0:100–33 MPa  7. The 50:50 and
100:0 formulations exhibited signiﬁcantly lower moduli
when hydrated, with 100:0 scaffolds possessing a modulus
of 136 MPa  61 while dry, but when wet the material was
too fragile to measure. The moduli of the 50:50 scaffolds
changed from an average of 57 MPa  18 while dry to
4 MPa  0.2 once hydrated.
Crosslinking of the 100:0 scaffold resulted in the increase
of the Young’s modulus signiﬁcantly in the dry testing regime
[Figure 3(A)], with increasing modulus from 136 MPa  6 to
1858 MPa  47 (CL). Non-CL100:0 scaffolds in the hydrated
state could not be tested due to a loss of integrity of the scaf-
fold after hydration [Figure 3(B)]. Crosslinking had little
effect on the mechanical properties of the 50:50, 75:25, and
0:100 scaffolds in both dry and hydrated states. When com-
pared to full thickness cornea tensile testing (3–13 MPa25),
50:50 scaffolds appeared to most closely ﬁt the observed
range with a modulus of 5.5 MPa  0.8. Elongation at break
in the dry testing regime increased with increasing PCL
content ranging from 0.014  0.003 mm/mm (100:0) up
to 0.229  0.100 mm/mm [0:100; Figure 3(C)]. PCL 0:100
scaffolds were able to reach over 20% extension before
failure, irrespective of hydration [Figure 3(C,D)]. Elonga-
tion at break of gelatin containing scaffolds was seen
to increase with hydration; 0.066  0.044 mm/mm when
dry (50:50) to 0.386  0.082 mm/mm when hydrated
[Figure 3(D)].
Fibrous scaffolds were biocompatible for hCSC with PCL
scaffolds containing gelatin supporting a quiescent
keratocyte phenotype
The biocompatibility of 100:0 CL scaffolds along with 50:50;
25:75; and 0:100 scaffolds were compared in terms of hCSC
adhesion and proliferation on the scaffolds. Over a 5 h
period, signiﬁcantly more hCSC adhered to 100:0 CL scaf-
folds than the 0:100 scaffolds observed through a difference
in relative ﬂuorescence of 514  51 Relative Fluorescence
Units (RFU) for cells cultured on 100:0 CL relative to
277  37 for cells on 0:100 scaffolds [PrestoBlue; Figure 4
(A)]. However, there were no signiﬁcant differences between
hCSC adherence to 100:0 CL, 50:50 or 25:75 scaffolds
[Figure 4(A)]. hCSC were able to proliferate over a 12 day
FIGURE 4. (A) hCSC adhesion to electrospun scaffolds 5 h post-seeding as measured by the PrestoBlue assay. Values represented by mean  SEM,
n = 4, *p < 0.05; (B) hCSC proliferation on electrospun membranes over 12 days. Values represented by mean  SEM, n = 2 (n = 2; triplicate scaf-
folds in each experiment); (C) Water contact angle of gelatin and PCL surfaces after dip coating procedure. Mean  SEM, n = 5; (D) Adhesion of
hCSC on coated glass coverslips after 5 h. Mean  SEM, (n = 3; triplicate scaffolds in each experiment), *p < 0.05.
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period on all four electrospun scaffolds at similar rates
[Figure 4(B)].
Assessment of the effects of surface chemistry on adhe-
sion, without potential differences in topography, was per-
formed using glass coverslips dip-coated in HFIP solutions of
each of the formulations [conﬁrmed by WCA measurements;
Figure 4(C)]. A similar hCSC adhesion experiment was per-
formed [Figure 4(D)] and similar trends were observed on
the coated glass coverslips as observed on the ﬁbrous scaf-
folds. A difference in relative ﬂuorescence determined in the
PrestoBlue assay of 994  103 for cells cultured on 100:0
CL coated glass coverslips was observed relative to
501  54 for cells on 0:100 coated glass coverslips. How-
ever, in contrast to the data generated with the ﬁbrous scaf-
folds, the 100:0 CL coated glass also supported signiﬁcantly
higher hCSC adhesion than 50:50 or 25:75 coated glass.
qPCR was used to assess gene expression of two markers
of the quiescent (non-scarring) keratocyte phenotype,
ALDH3A1 and CD34, and two markers of the activated (scar-
ring) ﬁbroblast phenotype, ACTA2 (α-SMA) and THY1 (CD90).
Gene expression data were compared to cells cultured on the
gelatin scaffold rather than the native cornea stromal tissue
as the cells had been cultured in vitro prior to these experi-
ments. Overall relative gene expression responses to the elec-
trospun substrates were small with a fourfold increase being
the greatest response observed in all experiments [Figure 5
(A)]. Statistically signiﬁcant increases in ALDH expression
were observed in hCSC cultured on the both 50:50 and 25:75
scaffolds relative to 100:0 CL. hCSC cultured on 0:100 scaf-
folds expressed signiﬁcantly more THY1 than those on 100:0
CL. To assess the direct effect of crosslinking on the phenotype
of hCSC, cells were cultured on 50:50 scaffolds with and with-
out crosslinking and phenotype was assessed [Figure 5(B)].
Scaffolds 50:50 and 50:50 CL differed little in terms of
CD34 and THY1 expression in this experiment. ACTA2
expression was the largest and only statistically signiﬁcant
difference recorded which was increased when cells were
cultured on CL samples [Figure 5(B)]. This phenomenon was
explored further though assessing protein expression by
immunoﬂuorescence (Figure 6). Cells were clearly situated
in a layer on top of the scaffolds and hCSC cultured on 50:50
scaffolds which had not been CL were seen to express higher
levels of CD34 and CD90. α-SMA appears to be expressed to
a higher degree by hCSC cells cultured on 50:50 CL scaffolds.
Macroscopic images captured after 12 days culture with or
without hCSCs in K medium showed that 100:0 CL scaffolds
were more transparent than any PCL containing scaffold
(Figure 7). No differences were observed between the other
scaffold types with or without hCSC.
DISCUSSION
A global shortage of corneal donor tissue, coupled with
increasing levels of adoption of DALK has resulted in a need
for partial thickness corneal tissue grafts.1 The development
of tissue-engineered stromal replacements hold promise to
supplement the donor tissue pool in addition to producing
standardized constructs. We anticipate that the use of such
stromal constructs to be suitable for DALK procedures used
in clinical situations where the endothelium remains intact
yet there is a need to support stromal replacement. Such
constructs would allow the surgeon ﬂexibility to replace the
stroma layer by layer depending on the depth of the injury.
Re-epithelialization would then occur from the patient’s own
limbal stem cell reserve or in combination with limbal stem
cell transplantation.
Our approach proposes the use of polymeric platforms,
produced by electrospinning, as biomimetic constructs for
corneal tissue regeneration. More speciﬁcally, this article
compares the attributes of gelatin and PCL electrospun
blends relative to chemically CL gelatin as a novel way to
produce suitable candidates for stromal replacement. This
work represents the ﬁrst time an electrospun composite of
synthetic and natural polymers has been evaluated as a can-
didate material for corneal stromal tissue engineering.
Gelatin was chosen on account of its bioactivity, biodegrad-
ability, non-antigenicity, current use in clinical applications, sta-
bility during electrospinning, and commercial availability at
FIGURE 5. hCSC gene expression in response to electrospun scaffolds
measured by qPCR. (A) hCSC gene expression after 12 days culture
upon four electrospun scaffolds in K media. All data normalized to
GAPDH and displayed relative to 100:0 CL. Data represented by mean
relative quantitation  SEM, (n = 3; triplicate samples); (B) hCSC gene
expression after 12 days culture upon 50:50 scaffolds with and without
GA crosslinking. All data normalized to GAPDH and displayed relative
to 50:50. Data represented by mean relative expression  SEM, (n = 3)
triplicate samples.*p < 0.05, **p < 0.01.
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low cost.10,11 PCL was chosen as an alternative to GA crosslink-
ing to provide strength to gelatin-based scaffolds as it is bio-
compatible, biodegradable and has been extensively explored
for applications in tissue engineering.18 The longer degradation
time of PCL (anticipated to be 6–12 months based on our
knowledge of PCL-based scaffolds) was attractive for the pro-
duction of ﬁbrous materials to contrast our experience with
other polymers, such as poly(lactic-co-glycolic acid) (PLGA),
which rapidly lose integrity when wet. The lack of transparency
of PCL was not considered an issue for clinical applications as
polymer degradation and tissue remodeling would allow for
restoration of sight; we show that the scaffolds are opaque and
this would be sufﬁcient for perception of light/dark following
surgery. We therefore wanted to explore the novel application
of PCL-gelatin blended scaffolds in ophthalmology.
In optimized electrospinning conditions, gelatin pro-
duced ribbon-like ﬁbers upon deposition in line with previ-
ous reports,17,26 whereas rounded ﬁbers were achieved in
all PCL containing scaffolds.27,28 Fiber diameter of gelatin-
based scaffolds was seen to decrease and the WCA increased
through introducing PCL. Other investigations of gelatin:PCL
blends have not reported such ﬁber diameter trends
although the WCA data agrees with other work.27–29 All
these studies, including our ﬁndings reported here, produced
ﬁbers an order of magnitude greater than the collagen ﬁbrils
found in vivo (31–34 nm) but are similar in diameter to
lamellae structures, which are ~1 to 2 μm thick.6,30 The dis-
tinct material compositions of the different gelatin:PCL
blends were successfully validated though ATR-FTIR. The
presence of both amide and ester bands in the 25:75 and
50:50 gelatin:PCL scaffolds conﬁrmed that both materials
were present at the surface of the scaffolds, as described in
the literature.30,31
The high solubility of gelatin in aqueous solutions meant
that crosslinking was required. Crosslinking of 100:0 gelatin
scaffolds with GA resulted in the webbing of individual ﬁbers
resulting in a signiﬁcant drop in the porosity of the scaffold.
Uniaxial tensile testing showed that GA crosslinking of 100:0
scaffolds signiﬁcantly increased the modulus and elongation
at break. The effect of GA treatment on the 50:50 and 25:75
scaffolds was not signiﬁcant, suggesting that the mechanical
properties of PCL dominate in this system. All scaffolds in
the hydrated state were capable of withstanding the same
level of strain before failure. The Young’s modulus of the
healthy human cornea has been previously reported to be
about 3 MPa,25,32 which corresponds to the measured
FIGURE 6. Immunoﬂuorescent staining of hCSC cultured on (A–J) 50:50 (G50) and (K–T) 50:50 CL (G50 CL) scaffolds for 12 days in K media. Scaf-
folds were ﬁxed with paraformaldehyde, wax embedded and sectioned at 8 μm. Sections were stained for either (B, G, L, Q) ALDH3A1; (C, H, M, R)
α-SMA; (D, I, N, S) CD34; and (E, J, O, T) CD90; (A, F, K, P). Unstained scaffolds, imaged by auto-ﬂuorescence. All sections counterstained with DAPI.
Auto-ﬂuorescence of unstained scaffolds (seeded with cells but not subjected to immunostaining) (U, V—50:50; W, X—50:50 CL) under (U, W) FITC
ﬁlter; (V, X) TRITC ﬁlter. (A–E; K–O; U–X) 400× magniﬁcation (scale bar: 50 μm); (F–J; P–T) ×600 magniﬁcation (scale bar: 20 μm).
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moduli of the hydrated 50:50 and 100:0 CL scaffolds. As the
concentration of PCL increased, the tensile moduli of the
scaffolds decreased as seen in other studies where gelatin is
included in the blend.16,17,31 In the hydrated state, this trend
was seen to reverse. The moduli of the gelatin scaffolds in
both 100:0 CL and 50:50 compositions decreased upon
hydration, when brittle ﬁbers swelled to become hydrogel-
like.26 Mechanical testing of gelatin-based electrospun scaf-
folds in the hydrated state has not been previously reported.
The degradation of the scaffolds produced was not studied
here (although they were visually intact for up to 21 days)
and would be a next step in further evaluating these scaf-
folds for clinical applications.
For application in corneal stroma repair, it was impor-
tant to evaluate the biocompatibility of the scaffolds with
hCSC. The cells adhered to all scaffolds of various composi-
tions with cell adhesion highest on the gelatin-based scaf-
folds suggesting that there was insufﬁcient, if any, GA
remaining to be detrimental to the cells. Experiments on 2D
controls of the same formulations demonstrated that chemis-
try was the dominant effect on cell adhesion in these studies
(rather than ﬁber morphology). ALDH3A133,34 and CD3435–37
are important markers of keratocytes in vivo alongside kera-
tocan expression.38,39 The expression of CD90 (gene name
THY1) and α-SMA (gene name ACTA2) are characteristic of a
less desirable myoﬁbroblastic phenotype that leads to scar-
ring.38 Our data suggested that 50:50 and 25:75 scaffolds
offer a substrate more supportive of the keratocyte pheno-
type, with decreased α-SMA and increased CD34 and
ALDH3A1 expression. Previous work published by our labo-
ratories have compared similar isolated cells cultured
in vitro to those resident in the native cornea. Compared to
the native cornea, ALDH3A1, CD34, and ACTA2 were signiﬁ-
cantly downregulated and THY1 was signiﬁcantly upregu-
lated.38 This suggests that when cultured in vitro, the whole
population of cells do not differentiate to the keratocyte phe-
notype warranting further optimization of scaffold morphol-
ogy and in vitro culture conditions. In addition, comparison
of the expression of these markers from in vitro cultured
cells with those expressed in vivo is further required.
In considering clinical therapies for the cornea, the refrac-
tive index of the scaffolds is an important factor.31,40 Gelatin
100:0 CL scaffolds demonstrated a higher transmittance of vis-
ible light and this increased following culture with hCSC sug-
gesting remodeling of the extracellular matrix. Longer culture
studies are required to assess matrix remodeling and degrada-
tion in the gelatin-PCL scaffolds in relation to transparency.
Further optimization of the ﬁber diameter to allow penetration
of the cells throughout the scaffold, while supporting the qui-
escent (non-scarring) cell phenotype, would also be a focus of
future work. Future in vivo studies would also be required to
ascertain the ability of these scaffolds to support the quiescent
(non-scarring) keratocyte phenotype in the longer term and
ultimately the restoration of visual acuity. In conclusion, we
have demonstrated for the ﬁrst time that hCSC cultured on
blended gelatin-PCL scaffolds adopt a therapeutically desirable
quiescent phenotype illustrating their suitability as future cor-
neal repair materials.
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